Patient-posture and Ileal-intubation During Colonoscopy
NCT ID: NCT01159886
Last Updated: 2010-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
216 participants
INTERVENTIONAL
2010-06-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supine Position for Colonoscopy Insertion
NCT03289442
Left Lateral Tilt-down Position During Colonoscopy Insertion
NCT02842489
Right or Left for Colonoscopy?
NCT02305706
Positioning During Colonoscopy
NCT01254435
Prone Versus Left-sided Colonoscopy in Obese Patients
NCT01616602
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
left lateral
After confirmation of cecal intubation, patient will undergo randomization to either the left-lateral decubitus position. Then terminal ileal intubation will be attempted.
Ileal intubation
After confirmation of cecal intubation, patient will undergo randomization to either the left-lateral decubitus or supine position. Then terminal ileal intubation will be attempted. Partial suction and scope manoeuvres for ileal intubation will be allowed.
Use of anti-peristalsis agents, use of biopsy forceps, as a guidewire or an ''anchor'' to facilitate the IC- valve intubation, and intubation in the retroflexed position will not be allowed.
supine
After confirmation of cecal intubation, patient will undergo randomization to the supine position. Then terminal ileal intubation will be attempted.
Ileal intubation
After confirmation of cecal intubation, patient will undergo randomization to either the left-lateral decubitus or supine position. Then terminal ileal intubation will be attempted. Partial suction and scope manoeuvres for ileal intubation will be allowed.
Use of anti-peristalsis agents, use of biopsy forceps, as a guidewire or an ''anchor'' to facilitate the IC- valve intubation, and intubation in the retroflexed position will not be allowed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ileal intubation
After confirmation of cecal intubation, patient will undergo randomization to either the left-lateral decubitus or supine position. Then terminal ileal intubation will be attempted. Partial suction and scope manoeuvres for ileal intubation will be allowed.
Use of anti-peristalsis agents, use of biopsy forceps, as a guidewire or an ''anchor'' to facilitate the IC- valve intubation, and intubation in the retroflexed position will not be allowed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Acute Intestinal obstruction
* Suspected intestinal perforation
* Peritonitis
* Pregnancy
* Severe cardio-respiratory disease (ASA grade…)
* Decompensated liver disease
* Recent pelvic or colonic surgery (in last 6 months)
* Large aortic or ileac artery aneurysm
* Human Immunodeficiency Virus Infection
* Uncooperative patients
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Associate Professor, Division of Gastroenterology, SDLD, IPGME & R, Kolkata-700020
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kshaunish Das, MD, DM
Role: PRINCIPAL_INVESTIGATOR
Associate Professor, Division of Gastroenterology, SDLD, IPGME & R, Kolkata-700020
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Digestive and Liver Diseases (SDLD), IPGME & R, Kolkata
Kolkata, , India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
K Das
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SDLD001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.